Diphenylhydantoin-induced pure red cell aplasia.
Pure red cell aplasia is an uncommon complication of diphenylhydantoin therapy. It has not been reported in Indian literature. Awareness of the entity helps in establishing the cause of anaemia in these patients and alerts the physicians to the need of comprehensive haematological monitoring in these patients. A case of 58-year-old male who developed pure red cell aplasia following three months of diphenylhydantoin therapy is reported here.
Rusia
Usha
U
Department of Pathology, University College of Medical Sciences & Guru Teg Bahadur Hospital, Delhi 110095.
Malhotra
Purnima
P
Joshi
Panul
P
D000927:Anticonvulsants / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000009:adverse effects*; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced*; D018570:Risk Assessment; D012307:Risk Factors
D000927:Anticonvulsants; D010672:Phenytoin